loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 761071 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ADALIMUMAB-ADAZ (1)

filter

01 SANDOZ INC (1)

filter

01 INJECTABLE;INJECTION (1)

filter

01 40MG/0.8ML (1)

filter

01 USA (1)

URL Supplier Web Content
INJECTABLE;INJECTION
40MG/0.8ML
HYRIMOZ
USA
761071
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 761071

Looking for CTD TGA MCC DOSSIER APPLICATION 761071 1

19

Sandoz B2B, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for A global leader in antibiotics.

One of their notable products is ADALIMUMAB-ADAZ, with a corresponding application number 761071 and regulatory information .

proudly manufactured in the

Sandoz B2B's HYRIMOZ INJECTABLE;INJECTION, medication with 40MG/0.8ML of ADALIMUMAB-ADAZ.

Post Enquiry
POST ENQUIRY